PharmaShots Weekly Snapshot (March 16-20, 2020)

1. Merck Collaborates with Dragonfly to Develop and Commercialize Novel Therapies Utilizing TriNKET Platform

Published: Mar 19, 2020 | Tags: Merck, Collaborates, Dragonfly, Develop, Commercialize, Novel Therapies, Utilizing, TriNKET Platform

2.  BGI Reports the Availability of RT-PCR SARS-CoV-2 Test for Clinical Use in the US

Published: Mar 20, 2020 | Tags: BGI, Reports, Availability, RT-PCR, SARS-CoV-2 Test, Clinical Use, US

3.  FDA Recommends Avoiding the Use of NSAIDs for COVID-19 Symptoms

Published: Mar 19, 2020 | Tags: FDA, Recommends, Avoiding, Use, NSAIDs, COVID-19 Symptoms

4. Abbott Launches its Molecular Test to Detect COVID-19 and Receives the US FDA’s Emergency Use Authorization

Published: Mar 18, 2020 | Tags: Abbott, Launches, Molecular Test, Detect, COVID-19, Receives, US, FDA, Emergency Use Authorization

5.  Gilead’s Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA’s Approval for Children with Chronic Hepatitis C Infection

Published: Mar 19, 2020 | Tags: Gilead, Epclusa, Sofosbuvir/Velpatasvir, Receives, US, FDA, Approval, Children, Chronic Hepatitis C Infection

6.  CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19

Published: Mar 18, 2020 | Tags: CEPI, Collaborates, University of Hong Kong, Develop, Vaccine, COVID-19

7. Janssen Reports Submission of Ponesimod’s NDA to the US FDA for the Treatment of Relapsing Multiple Sclerosis

Published: Mar 18, 2020 | Tags: Janssen, Reports, Submission, Ponesimod, NDA, US, FDA, Treatment, Relapsing, Multiple Sclerosis

8. FDA Divulges Guidance for Conducting Clinical Studies During COVID-19 Pandemic

Published: Mar 17, 2020 | Tags: FDA, Divulges, Guidance, Conducting, Clinical Studies, During, COVID-19 Pandemic

9. AstraZeneca’s Lynparza (olaparib) Receives MHLW’s Orphan Drug Designation for BRCA-Mutated Metastatic Pancreatic Cancer

Published: Mar 19, 2020 | Tags: AstraZeneca, Lynparza, olaparib, Receives, MHLW, Orphan Drug Designation, BRCA-Mutated, Metastatic Pancreatic Cancer

10. Eli Lilly and ISDH Collaborate to Accelerate the Testing for COVID-19

Published: Mar 18, 2020 | Tags: Eli Lilly, ISDH, Collaborate, Accelerate, Testing, COVID-19

11. Novartis’ Zolgensma (onasemnogene abeparvovec) Receives MHLW’s Approval for Spinal Muscular Atrophy

Published: Mar 19, 2020 | Tags: Novartis, Zolgensma, onasemnogene abeparvovec, Receives, MHLW, Approval, Spinal Muscular Atrophy

12. Roche to Initiate P-III COVACTA Study of Actemra/RoActemra in Hospitalized Patients with Severe Covid-19 Pneumonia in Collaboration with BARDA

Published: Mar 19, 2020 | Tags: Roche, Initiate, P-III, COVACTA Study, Actemra/RoActemra, Hospitalized Patients, Severe, Covid-19 Pneumonia, BARDA

13. Juno Therapeutics Signs License and Clinical Supply Agreement with Oxford Biomedica for LentiVector Platform

Published:  Mar 18, 2020 | Tags: Juno Therapeutics, Signs, License Agreement, Oxford Biomedica, LentiVector Platform

14. Samsung Biologics Collaborates with APRINOIA Therapeutics to Expand its Presence in Greater China

Published: Mar 16, 2020 | Tags: Samsung Biologics, Collaborates, APRINOIA Therapeutics, Expand, Presence, Greater China

15.  IDEAYA and Pfizer Collaborate to Evaluate IDE196 + Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations

Published: Mar 18, 2020 | Tags: IDEAYA, Pfizer, Collaborate, Evaluate, IDE196, Binimetinib, Solid Tumors, Harboring, GNAQ, GNA11, Hotspot Mutations

16.  Regeneron to Initiate COVID-19 Antibody Program in Early Summer

Published: Mar 17, 2020 | Tags: Regeneron, Initiate, COVID-19, Antibody Program, Early Summer

17. NuProbe Collaborates with QIAGEN to Develop Diagnostics Tests for Cancer Indications

Published: Mar 16, 2020 | Tags: NuProbe, Collaborates, QIAGEN, Develop, Diagnostics Tests, Cancer Indications

18. Merck & Co. Reports Results of Gefapixant (MK-7264) in Two P-III Studies for Refractory or Unexplained Chronic Cough

Published: Mar 17, 2020 | Tags: Merck & Co., Reports, Results, Gefapixant, MK-7264, Two, P-III Studies, Refractory, Unexplained, Chronic Cough

19. Moleculin Collaborates with UTMB to Evaluate WP1122 for Multiple Viruses Including Coronavirus

Published: Mar 17, 2020 | Tags:  Moleculin, Collaborates, UTMB, Evaluate, WP1122, Multiple Viruses, Coronavirus

20. NIH Initiates its P-I Trial for COVID-19 at KPWHRI in Seattle

Published: Mar 16, 2020 | Tags:  Novo Nordisk, Fiasp, insulin aspart injection, Receives, Health Canada, Approval, Children, Diabetes

21.  GSK’s Nucala Receives Health Canada’s Approval for Severe Eosinophilic Asthma in Children and Adolescents

Published: Mar 16, 2020 | Tags: GSK, Nucala, Receives, Health Canada, Approval, Severe Eosinophilic Asthma, Children, Adolescents

22. Alphabet’s Verily Launched its COVID-19 Screening Site in Collaboration with California’s Government

Published: Mar 16, 2020 | Tags: Alphabet, Verily, Launch, COVID-19, Screening Site, Collaboration, California Governor 

23.  AstraZeneca Reports Results of Imfinzi + Tremelimumab in P-III CASPIAN Study as 1L Treatment for Extensive-Stage Small Cell Lung Cancer

Published: Mar 17, 2020 | Tags: AstraZeneca, Reports, Results, Imfinzi, Tremelimumab, P-III, CASPIAN, Study, 1L, Treatment, Extensive-Stage Small Cell Lung Cancer

24.  AcelRx to Acquire Tetraphase Pharmaceuticals to Expand its Product Portfolio

Published: Mar 16, 2020 | Tags: AcelRx, Acquire, Tetraphase Pharmaceuticals, Expand, Product Portfolio

25. Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors

Published: Mar 17, 2020 | Tags: Novo Nordisk, Halts, Clinical Studies, Evaluating, Concizumab, (anti-TFPI mAb), Hemophilia A and B, With or Without Inhibitors

26. Pfizer and BioNTech Collaborate to Co-Develop BNT162 Against COVID-19

Published: Mar 17, 2020 | Tags: Pfizer, BioNTech, Collaborate, Co-Develop, BNT162, Against, COVID-19

27.  Teva and Celltrion Launch Herzuma (biosimilar, trastuzumab) in the US

Published: Mar 17, 2020 | Tags: Teva, Celltrion, Launch, Herzuma, biosimilar, trastuzumab, US

28. Sanofi and Regeneron to Initiate the Clinical Program Evaluating Kevzara (sarilumab) in Patients with Severe COVID-19

Published: Mar 16, 2020 | Tags: Sanofi, Regeneron, Initiate, Clinical Program, Evaluating, Kevzara, sarilumab, Patients, Severe, COVID-19

29. Biogen Collaborates with Vir Biotechnology to Develop Antibodies Against COVID-19

Published: Mar 12, 2020 | Tags: Biogen, Collaborates, Vir Biotechnology, Develop, Antibodies, Against, COVID-19

30. Eli Lilly and Incyte’s Olumiant (baricitinib) Receives the US FDA’s Breakthrough Therapy Designation for Alopecia Areata

Published: Mar 16, 2020 | Tags: Eli Lilly, Incyte, OLUMIANT, baricitinib, Receives, US, FDA, Breakthrough Therapy Designation, Alopecia Areata

31.  Fosun Pharma Signs an Agreement with BioNTech to Develop and Commercialize BNT162 for COVID-19

Published: Mar 16, 2020 | Tags: Fosun Pharma, Signs, Agreement, BioNTech, Develop, Commercialize, BNT162, COVID-19

32. Johnson & Johnson Collaborates with the Beth Israel Deaconess Medical Center to Accelerate the Development of Vaccine Against COVID-19

Published: Mar 13, 2020 | Tags: Johnson & Johnson, Collaborates, the Beth Israel Deaconess Medical Center, Accelerate, Development, Vaccine, Against, COVID-19